Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. (Q53963953)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

main subject

Colombia

0 references

cutaneous leishmaniasis

1 reference

mucocutaneous leishmaniasis

inferred from title

1 reference

inferred from title

Leishmania amazonensis

object named as

Leishmania amazonensis

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Fabio Zicker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Iván D Vélez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Katherine Gilchrist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Carlos A Rojas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Juan A Puerta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Carlos M F Antunes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Farrokh Modabber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

Transactions of the Royal Society of Tropical Medicine and Hygiene

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

593-598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

Controlled field trials of a vaccine against New World cutaneous leishmaniasis.

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Leishmaniasis: Immunological and clinical aspects and vaccines in Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

The epidemiology and control of leishmaniasis in Andean countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Leishmaniasis. Public health aspects and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Leishmaniasis: current status of vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Monoclonal antibodies that distinguish between New World species of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

A randomized double-blind placebo-controlled trial to evaluate the immunogenicity of a candidate vaccine against American tegumentary leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

A field trial of a vaccine against American dermal leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Vaccines against leishmaniasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

Distribution and etiology of leishmaniasis in Colombia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

7 January 2021

inferred from DOI database lookup

Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.04.002

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.TRSTMH.2005.04.002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15893351%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference